Endothelial dysfunction predicts regression of hypertensive cardiac mass

International Journal of Cardiology

Volumn 167, Issue 4, 2013, Pages 1188-1192

  Perticone, Francesco ^a   Maio, Raffaele ^a   Perticone, Maria ^a   Miceli, Sofia ^a   Sciacqua, Angela ^a   Tassone, Eliezer J ^a   Shehaj, Ermal ^a   Tripepi, Giovanni ^b   Sesti, Giorgio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b CNR   (Italy)

Author keywords

Endothelial function; Hypertension; Left ventricular mass

Indexed keywords

ACETYLCHOLINE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; FOLLOW UP; FOREARM BLOOD FLOW; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; VASCULAR ENDOTHELIUM; VASODILATATION;

ENDOTHELIAL FUNCTION; HYPERTENSION; LEFT VENTRICULAR MASS;

ADULT; AGED; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REMISSION, SPONTANEOUS; VASODILATION;

EID: 84881478126     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.03.138     Document Type: Article

References (45)

1. D. Levy, R.J. Garrison, D.D. Savage, W.B. Kannel, and W.P. Castelli Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study N Engl J Med 322 1990 1561 1566
2. H.H. Parving Initiation and progression of diabetic nephropathy N Engl J Med 335 1996 1682 1683
3. D.H. O'Leary, J.F. Polak, R.A. Kronmal, T.A. Manolio, G.L. Burke, and S.K. Wolfson Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group N Engl J Med 340 1999 14 22
4. F. Perticone, R. Ceravolo, and A. Pujia Prognostic significance of endothelial dysfunction in hypertensive patients Circulation 104 2001 191 196
5. F.U. Mattace-Raso, T.J. van der Cammen, and A. Hofman Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study Circulation 113 2006 657 663
6. G. Cerasola, S. Cottone, and G. Mulè The progressive pathway of microalbuminuria: from early marker of renal damage to strong cardiovascular risk predictor J Hypertens 28 2010 2357 2369
7. M. Tonelli, N. Wiebe, and B. Culleton Chronic kidney disease and mortality risk: a systematic review J Am Soc Nephrol 17 2006 2034 2047
8. R. Maio, A. Sciacqua, and R. Bruni Association between hemoglobin level and endothelial function in uncomplicated, untreated hypertensive patients Clin J Am Soc Nephrol 6 2011 648 655
9. A. Sciacqua, S. Miceli, and G. Carullo One-hour postload plasma glucose levels and left ventricular mass in hypertensive patients Diabetes Care 34 2011 1406 1411
10. G. Mancia, S. Laurent, and E. Agabiti-Rosei European Society of Hypertension Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document J Hypertens 27 2009 2121 2158
11. P.O. Bonetti, L.O. Lerman, and A. Lerman Endothelial dysfunction: a marker of atherosclerotic risk Arterioscler Thromb Vasc Biol 23 2003 168 175
12. F. Perticone, R. Maio, and A. Sciacqua Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension Diabetes 57 2008 167 171
13. J.P. Halcox, A.E. Donald, and E. Ellins Endothelial function predicts progression of carotid intima-media thickness Circulation 119 2009 1005 1012
14. F. Perticone, R. Maio, and M. Perticone Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patients Circulation 122 2010 379 384
15. F. Perticone, R. Maio, R. Ceravolo, C. Cosco, C. Cloro, and P.L. Mattioli Relationship between left ventricular mass and endothelium-dependent vasodilation in never-treated hypertensive patients Circulation 99 1999 1991 1996
16. G. Schillaci, P. Verdecchia, C. Porcellati, O. Cuccurullo, C. Cosco, and F. Perticone Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension Hypertension 35 2000 580 586
17. A. Ilercil, R.B. Devereux, and M.J. Roman Relationship of impaired glucose tolerance to left ventricular structure and function: the Strong Heart Study Am Heart J 141 2001 992 998
18. F. Perticone, R. Maio, and C. Ruberto Kidney function and risk factors for left ventricular hypertrophy in untreated uncomplicated essential hypertension Am J Kidney Dis 52 1 2008 Jul 74 84
19. P. Verdecchia, F. Angeli, and C. Borgioni Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis Am J Hypertens 16 2003 895 899
20. S.D. Pierdomenico, D. Lapenna, and F. Cuccurullo Risk reduction after regression of echocardiographic left ventricular hypertrophy in hypertension: a meta-analysis Am J Hypertens 23 2010 876 881
21. M.D. Cheitlin, W.F. Armstrong, and G.P. Aurigemma American College of Cardiology; American Heart Association; American Society of Echocardiography. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography) Circulation 108 2003 1146 1162
22. R.B. Devereux, D.R. Alonso, and E.M. Lutas Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings Am J Cardiol 57 1986 450 458
23. J.A. Panza, A.A. Quyyumi, J.E. Brush, and S.E. Epstein Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension N Engl J Med 323 1990 22 27
24. F. Šimko, and J. Šimko The potential role of nitric oxide in the hypertrophic growth of the left ventricle Physiol Res 49 2000 37 46
25. U.C. Garg, and A. Hassid Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells J Clin Invest 83 1989 1774 1777
26. V. Kolpakov, D. Gordon, and T.J. Kulik Nitric-oxide generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells Circ Res 76 1995 305 309
27. R.H. Ritchie, R.J. Schienbinger, M.C. Lapointe, and J.D. Marsh Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide Am J Physiol 275 1998 H1370 H1374
28. H. Matsuoka, M. Nakata, and K. Kohno Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats Hypertension 27 1996 14 18
29. K. Takaory, S. Kim, K. Ohta, A. Hamaguchi, K. Yagi, and H. Iwao Inhibition of nitric oxide synthase causes cardiac phenotypic modulation in rat Eur J Pharmacol 12 1997 59 62
30. T. Nakamura, T. Kurashina, and Y. Saito ETA receptor antagonist ameliorates nephrosclerosis and left ventricular hypertrophy induced in rat by prolonged inhibition of nitric oxide synthesis Hypertens Res 21 1998 251 257
31. J.D. Banting, K.E. Thompson, P. Friberg, and M.A. Adams Blunted cardiovascular growth induction during prolonged nitric oxide synthase blockade Hypertension 30 1997 416 421
32. B.B. Matsubara, L.S. Matsubara, L.A. Zornoff, M. Franco, and J.S. Janicki Left ventricular adaptation to chronic pressure overload induced by inhibition of nitric oxide synthase in rats Basic Res Cardiol 93 1998 173 181
33. L.M.M. Pereira, and C.A. Mandarim de Lacerda Myocardial microcirculation stereological changes in rats subjected to nitric oxide synthesis inhibition Pathol Res Pract 195 1999 177 181
34. N. Akuzawa, T. Nakamura, and T. Kurashina Antihypertensive agents prevent nephrosclerosis and left ventricular hypertrophy induced in rats by prolonged inhibition of nitric oxide synthesis Am J Hypertens 11 1998 697 707
35. M. Endres, and U. Laufs Effects of statin on endothelium and signaling mechanisms Stroke 35 2004 2708 2711
36. F. Šimko Statins: a perspective for left ventricular hypertrophy treatment Eur J Clin Invest 37 2007 681 691
37. M. Takemoto, K. Node, and H. Nakagami Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy J Clin Invest 108 2001 1429 1437
38. M. Higashi, H. Shimokawa, and T. Hattori Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD (P) H oxidase system Circ Res 93 2003 767 775
39. J.D. Luo, and A.F. Chen Perspectives on the cardioprotective effect of statins Curr Med Chem 10 2003 1593 1601
40. H. Aoki, S. Izumo, and J. Sadoshima Angiotensin II activates RhoA in cardiac myocytes: a critical role of Rho A in angiotensin II-induced premyofibril formation Circ Res 82 1998 666 676
41. S.J. Marchais, A.P. Guerin, B.M. Pannier, B.I. Levy, M.E. Safar, and G.M. London Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size Hypertension 22 1993 876 883
42. I.B. Wilkinson, A. Qasem, C.M. McEniery, D.J. Webb, A.P. Avolio, and J.R. Cockcroft Nitric oxide regulates local arterial distensibility in vivo Circulation 105 2002 213 217
43. R. Ceravolo, R. Maio, and A. Pujia Pulse pressure and endothelial dysfunction in never-treated hypertensive patients J Am Coll Cardiol 41 2003 1753 1758
44. A. Sciacqua, A. Scozzafava, and A. Pujia Interaction between vascular dysfunction and cardiac mass increases the risk of cardiovascular outcomes in essential hypertension Eur Heart J 26 2005 921 927
45. A.P. Avolio, L.M. Van Bortel, and P. Boutouyrie Role of pulse pressure amplification in arterial hypertension. Experts' opinion and review of the data Hypertension 54 2009 375 383